Abhay P S Rathore Selected Research

celgosivir

1/2016	Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.
8/2014	Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.
10/2012	Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.
12/2011	Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abhay P S Rathore Research Topics

Disease

12	Infections 11/2019 - 12/2011
11	Dengue (Dengue Fever) 12/2021 - 12/2011
4	Severe Dengue 12/2021 - 04/2013
4	Inflammation (Inflammations) 06/2021 - 03/2014
2	Thrombocytopenia (Thrombopenia) 01/2020 - 01/2019
2	Fever (Fevers) 11/2017 - 08/2014
1	Hypersensitivity (Allergy) 11/2020
1	Hypovolemia 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 11/2019
1	Microcephaly 01/2019
1	Obesity 11/2017
1	Mosquito-Borne Diseases 08/2014
1	Viremia 12/2011
1	Melanoma (Melanoma, Malignant) 05/2011

Drug/Important Bio-Agent (IBA)

4	Antiviral Agents (Antivirals)IBA 01/2021 - 05/2011
4	Chymases (Chymase)IBA 01/2020 - 04/2013
4	celgosivirIBA 01/2016 - 12/2011
3	AntibodiesIBA 12/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2013
3	Proteins (Proteins, Gene)FDA Link 03/2014 - 01/2012
2	AllergensIBA 06/2021 - 11/2020
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
2	CytokinesIBA 12/2011 - 05/2011
1	Immunoglobulin E (IgE)IBA 11/2020
1	neonatal Fc receptorIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	EpitopesIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	Ketotifen (Ketotifene)FDA Link 01/2017
1	castanospermineIBA 01/2016
1	GlucosidasesIBA 08/2014
1	VaccinesIBA 03/2014
1	geldanamycinIBA 03/2014
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 04/2013
1	Monoclonal AntibodiesIBA 01/2012
1	ChemokinesIBA 05/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2011

Therapy/Procedure

2	Therapeutics 01/2017 - 03/2014
1	Treatment Delay 10/2012
1	Aftercare (After-Treatment) 12/2011